Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCFO4Life Group, LLC
Latest Disclosed Ownership1,306 shares
Latest Disclosed Value $ 459,406
CFO4Life Group, LLC reports 32.51% decrease in ownership of AMGN / Amgen Inc.

On May 11, 2026 - CFO4Life Group, LLC filed a 13F-HR form disclosing ownership of 1,306 shares of Amgen Inc. (MX:AMGN) valued at $459,406 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 1,935 shares of Amgen Inc.. This represents a change in shares of -32.51% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F AMGEN COM 031162100 1,306 -629 -32.51 459 -27.49 0.0700
2026-02-06 2025-12-31 13F AMGEN COM 031162100 1,935 -5 -0.26 633 15.72 0.0903
2025-11-07 2025-09-30 13F AMGEN COM 031162100 1,940 14 0.73 547 1.86 0.0795
2025-08-08 2025-06-30 13F AMGEN COM 031162100 1,926 -114 -5.59 538 -15.43 0.0841
2025-04-30 2025-03-31 13F AMGEN COM 031162100 2,040 -110 -5.12 635 13.39 0.1070
2025-02-10 2024-12-31 13F AMGEN COM 031162100 2,150 6 0.28 560 -18.84 0.0984
2024-11-12 2024-09-30 13F AMGEN COM 031162100 2,144 50 2.39 691 5.50 0.1223
2024-07-31 2024-06-30 13F AMGEN COM 031162100 2,094 -75 -3.46 654 6.17 0.1230
2024-05-06 2024-03-31 13F AMGEN COM 031162100 2,169 84 4.03 617 2.67 0.1119
2024-02-12 2023-12-31 13F/A-1 AMGEN COM 031162100 2,085 -198 -8.67 601 -2.12 0.1147
2024-01-24 2023-12-31 13F AMGEN COM 031162100 2,085 -198 601 0.1147
2023-10-30 2023-09-30 13F AMGEN COM 031162100 2,283 -37 -1.59 614 19.03 0.1416
2023-08-07 2023-06-30 13F AMGEN COM 031162100 2,320 114 5.17 515 -3.38 0.1105
2023-05-03 2023-03-31 13F AMGEN COM 031162100 2,206 -153 -6.49 533 -13.89 0.1212
2023-02-03 2022-12-31 13F AMGEN COM 031162100 2,359 185 8.51 620 26.33 0.1317
2022-10-19 2022-09-30 13F AMGEN COM 031162100 2,174 -56 -2.51 490 -9.93 0.1304
2022-07-20 2022-06-30 13F AMGEN COM 031162100 2,230 46 2.11 544 3.03 0.1350
2022-05-02 2022-03-31 13F AMGEN COM 031162100 2,184 6 0.28 528 7.76 0.1108
2022-02-10 2021-12-31 13F AMGEN COM 031162100 2,178 626 40.34 490 48.48 0.1013
2021-10-12 2021-09-30 13F AMGEN COM 031162100 1,552 -155 -9.08 330 -20.67 0.0768
2021-07-14 2021-06-30 13F AMGEN COM 031162100 1,707 71 4.34 416 2.21 0.0960
2021-04-20 2021-03-31 13F AMGEN COM 031162100 1,636 -223 -12.00 407 -4.68 0.1012
2021-01-12 2020-12-31 13F AMGEN COM 031162100 1,859 100 5.69 427 -4.47 0.1225
2020-10-13 2020-09-30 13F AMGEN COM 031162100 1,759 2 0.11 447 7.97 0.1513
2020-07-15 2020-06-30 13F AMGEN COM 031162100 1,757 -144 -7.57 414 7.53 0.1591
2020-04-16 2020-03-31 13F AMGEN COM 031162100 1,901 -1,684 -46.97 385 -55.44 0.2059
2020-01-22 2019-12-31 13F AMGEN COM 031162100 3,585 46 1.30 864 26.13 0.3652
2019-11-01 2019-09-30 13F AMGEN COM 031162100 3,539 -16 -0.45 685 4.58 0.3071
2019-07-29 2019-06-30 13F AMGEN COM 031162100 3,555 101 2.92 655 -0.15 0.2993
2019-04-22 2019-03-31 13F AMGEN COM 031162100 3,454 -384 -10.01 656 -12.18 0.3073
2019-02-01 2018-12-31 13F AMGEN COM 031162100 3,838 -223 -5.49 747 -11.28 0.3285
2018-10-25 2018-09-30 13F AMGEN COM 031162100 4,061 -534 -11.62 842 -0.71 0.3733
2018-08-01 2018-06-30 13F AMGEN COM 031162100 4,595 279 6.46 848 15.22 0.3539
2018-05-07 2018-03-31 13F AMGEN COM 031162100 4,316 -2,708 -38.55 736 -39.72 0.6223
2018-01-22 2017-12-31 13F AMGEN COM 031162100 7,024 -115 -1.61 1,221 -8.26 0.9598
2017-11-09 2017-09-30 13F AMGEN COM 031162100 7,139 173 2.48 1,331 10.92 1.0733
2017-08-08 2017-06-30 13F AMGEN COM 031162100 6,966 195 2.88 1,200 8.01 1.1050
2017-05-11 2017-03-31 13F AMGEN COM 031162100 6,771 6,771 1,111 1.0079
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.